The American Journal of Medicine
Volume 102, Issue 3 , Pages 232-238, March 1997

Cocaine effects on digital blood flow and diffusing capacity for carbon monoxide among chronic cocaine users**

    MB, ChB
  • John T. Sullivan

      Affiliations

    • Corresponding Author InformationRequests for reprints should be addressed to Dr. J.T. Sullivan, Bayer Corporation, 400 Morgan Lane, West Haven, Connecticut 06516.
    • From the Departments of Medicine, Psychiatry, Johns Hopkins University School of Medicine and Johns Hopkins Bayview Medical Center, Baltimore, Maryland USA
  • , MD
  • Patrice M. Becker

      Affiliations

    • From the Departments of Medicine, Psychiatry, Johns Hopkins University School of Medicine and Johns Hopkins Bayview Medical Center, Baltimore, Maryland USA
  • , PhD
  • Kenzie L. Preston

      Affiliations

    • From the Behavioral Sciences, Johns Hopkins University School of Medicine and Johns Hopkins Bayview Medical Center, Baltimore, Maryland USA
  • , MD
  • Robert A. Wise

      Affiliations

    • From the Departments of Medicine, Psychiatry, Johns Hopkins University School of Medicine and Johns Hopkins Bayview Medical Center, Baltimore, Maryland USA
  • , MD
  • Frederick M. Wigely

      Affiliations

    • From the Departments of Medicine, Psychiatry, Johns Hopkins University School of Medicine and Johns Hopkins Bayview Medical Center, Baltimore, Maryland USA
  • , RN, MS
  • Margaret P. Testa

      Affiliations

    • From the Departments of Medicine, Psychiatry, Johns Hopkins University School of Medicine and Johns Hopkins Bayview Medical Center, Baltimore, Maryland USA
  • , MD
  • Donald R. Jasinski

      Affiliations

    • From the Departments of Medicine, Psychiatry, Johns Hopkins University School of Medicine and Johns Hopkins Bayview Medical Center, Baltimore, Maryland USA

Received 10 October 1995; received in revised form 18 November 1996

Purpose

To determine the acute effects of intravenous (IV) cocaine on primarily digital skin blood flow and diffusion capacity for carbon monoxide (CO), and secondarily on subjective and cardiovascular measures.

Patients and Methods

A double-blind, Latinsquare, placebo-controlled, dose-response study was conducted in an inpatient general clinical research center and clinical pharmacology unit of a university teaching hospital. Twelve adult males with histories of illicit drug use including IV cocaine received 0, 25, and 50 mg of IV cocaine given as 1-minute infusions, on 3 consecutive test days. Digital cutaneous blood flow was determined via laser doppler flowmetry and skin temperature. Diffusing capacity for carbon monoxide (DCO) was measured with standard techniques. Subjective responses were measured by oral report of a numerical ranking of strength of drug effect. Heart rate and blood pressure responses were measured by electronic syphygmomanometer.

Results

A maximal decrease in skin blood flow occurred at 2 to 3 minutes after infusion, and was not distinguished among drug conditions. Blood flow returned to baseline more rapidly after placebo than after cocaine: 7 minutes (placebo), 35 minutes (25 mg cocaine), 50 minutes (50 mg cocaine). Skin temperature decreased by 1.25 °C after placebo and by 2.75 and 3.25 °C after 25 and 50 mg of cocaine, respectively. DCO changed by −1.02 (mean) ± 0.25 (standard deviation), 0.16 ± 1.22, and 0.21 ± 1.63 ml/min/mm Hg following placebo, 25, and 50 mg of cocaine, respectively. Typical subjective, chronotropic, and pressor responses to cocaine were demonstrated, and these occurred in close temporal relationship to digital blood flow and skin temperature responses.

Conclusions

The digital cutaneous circulation is highly sensitive to vasoconstrictor effects of cocaine. Pulmonary blood volume tends to be preserved after IV cocaine. Subjective effects and cardiovascular responses occur in concert with peripheral blood flow changes. The peripheral vasoconstrictor effects have implications for cocaine users with concurrent vasospastic or vasculopathic disorders.

No full text is available. To read the body of this article, please view the PDF online.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

** This research was supported by United States Public Health Service research grants DA 06120 & 5 MO1 RR02719.

PII: S0002-9343(96)00453-6

doi:10.1016/S0002-9343(96)00453-6

The American Journal of Medicine
Volume 102, Issue 3 , Pages 232-238, March 1997